<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02103205</url>
  </required_header>
  <id_info>
    <org_study_id>LIME2014</org_study_id>
    <nct_id>NCT02103205</nct_id>
  </id_info>
  <brief_title>Effect of Infant Formula With Bovine Lactoferrin and Low Iron Concentration on Infant Health and Immune Function</brief_title>
  <acronym>LIME</acronym>
  <official_title>Effect of Infant Formula With Bovine Lactoferrin and Low Iron Concentration on Infant Health and Immune Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Umeå University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of California</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mead Johnson Nutrition</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Umeå University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Breast milk is the gold standard of early infant nutrition and breastfed infants have
      advantages in several short and long term outcomes compared to those formula-fed.

      The first aim of this study is to evaluate the effect of adding bovine lactoferrin to infant
      formula. The general hypothesis is that bovine lactoferrin reduces some of the previously
      observed differences between formula-fed and breast-fed infants with regard to health and
      development. The main outcome studied is the effect on immune function. The second aim is to
      study the effects of lower iron concentration in infant formula and to test the hypothesis
      that iron can be lowered without negative effects on health and development. The main outcome
      studied here is iron status. Other outcomes in this trial are microbiota composition,
      metabolomics, growth, body composition and cognitive development.

      To test the lactoferrin hypothesis, formula-fed infants will be recruited and fed a low iron
      (2 mg/L) control formula, or the same formula supplemented with bovine lactoferrin. To test
      the iron hypothesis, a third group will be fed the same formula (no lactoferrin) with higher
      iron concentration (8 mg/L). Group allocation for all formula-fed infants will be
      double-blind randomized. Additionally, breast-fed infants will be recruited and used as a
      reference group (gold standard).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of infections</measure>
    <time_frame>Up to 12 months of age</time_frame>
    <description>Morbidity journal, Health questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cytokine levels</measure>
    <time_frame>At 6 months of age</time_frame>
    <description>IL-2, TNF-alpha</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Iron status</measure>
    <time_frame>At 6 months of age</time_frame>
    <description>s-ferritin, s-transferrin, s-iron, s-transferrin receptor concentration, reticulocyte Hb</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dietary intake</measure>
    <time_frame>At baseline, 3, 4, 5, 6 and 12 months of age</time_frame>
    <description>Dietary journal</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Growth</measure>
    <time_frame>At baseline, 4, 6, 12 months of age and 6 years of age</time_frame>
    <description>Anthropometric data, Body Composition (PeaPod)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bloodpressure</measure>
    <time_frame>At baseline, 4, 6, 12 months of age and 6 years of age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antibody response to vaccines</measure>
    <time_frame>At baseline, 4, 6 and 12 months of age</time_frame>
    <description>s-levels of specific antibodies to vaccines (DTP, Hib, PC)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gut microbiota</measure>
    <time_frame>At baseline, 4, 6, 12 months of age and 6 years of age</time_frame>
    <description>Stool samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Saliva proteins</measure>
    <time_frame>At 4 months of age</time_frame>
    <description>Saliva total protein content, lactoferrin, saliva-peroxidase, IgA and amylase</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory markers</measure>
    <time_frame>At baseline, 4, 6 and 12 months of age and 6 years age</time_frame>
    <description>s-hsCRP, s-calprotectin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive development and behavior</measure>
    <time_frame>At 1 and 6 years of age</time_frame>
    <description>Bayley III, Wechsler Intelligence Scale for Children (WISC), Behavioral questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>s-hepcidin</measure>
    <time_frame>At baseline, 4, 6, 12 months of age and 6 years of age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolomics</measure>
    <time_frame>At baseline, 4, 6, 12 months of age and 6 years of age</time_frame>
    <description>Analyzed in urine and serum samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amino acids</measure>
    <time_frame>At 4 and 6 months of age</time_frame>
    <description>p-amino acids</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood urea nitrogen</measure>
    <time_frame>At 4 and 6 months of age</time_frame>
    <description>p-urea nitrogen</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cytokine levels</measure>
    <time_frame>At baseline, 4, 6, 12 months of age and 6 years of age</time_frame>
    <description>IL-2 and TNF alpha at baseline, 4 and 12 months of age and 6 years of age. Six additional cytokines at baseline, 4, 6 and 12 months of age and 6 years of age.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Iron status</measure>
    <time_frame>At baseline, 4 and 12 months of age and 6 years of age</time_frame>
    <description>s-ferritin, s-transferrin, s-iron, s-transferrin saturation, s-transferrin receptor concentration, retuiculocyte Hb</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Lactoferrin in breastmilk</measure>
    <time_frame>At baseline, 4 and 6 months of age</time_frame>
    <description>Analyzed from mothers to the control group of breast fed infants.</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">252</enrollment>
  <condition>Health of Formula-fed Children</condition>
  <condition>Infant Infections in Formula-fed Children</condition>
  <condition>Iron Status of Formula-fed Children</condition>
  <arm_group>
    <arm_group_label>Low iron, with lactoferrin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Low iron, with lactoferrin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low iron, no lactoferrin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Low iron, no lactoferrin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal iron, no lactoferrin</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Normal iron, no lactoferrin</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Formula with low iron concentration (2 mg/L) supplemented with bovine lactoferrin</intervention_name>
    <arm_group_label>Low iron, with lactoferrin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Formula with low iron concentration (2mg/L) without lactoferrin</intervention_name>
    <arm_group_label>Low iron, no lactoferrin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Formula with normal iron concentration (8 mg/L) without lactoferrin</intervention_name>
    <arm_group_label>Normal iron, no lactoferrin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Formula-fed healthy infants at 6 +/- 2 weeks of age with:

          -  birth weight 2500-4500 g

          -  gestational age at birth ≥ 37 completed weeks

          -  no chronic disease or neonatal diagnoses believed to affect any outcome

          -  no given blood transfusions or iron supplements

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>8 Weeks</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Staffan K Berglund, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Umeå University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Olle Hernell, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Umeå University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bo Lönnerdal, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carolyn Slupsky, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Staffan K Berglund, MD, PhD</last_name>
    <phone>+46907852370</phone>
    <email>staffan.berglund@pediatri.umu.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Umeå University, Department of Clinical Sciences</name>
      <address>
        <city>Umeå</city>
        <zip>SE-901 87</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Staffan K Berglund, MD, PhD</last_name>
      <phone>+46907852370</phone>
      <email>staffan.berglund@pediatri.umu.se</email>
    </contact>
    <investigator>
      <last_name>Staffan K Berglund, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olle Hernell, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Björmsjö, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 31, 2014</study_first_submitted>
  <study_first_submitted_qc>March 31, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 3, 2014</study_first_posted>
  <last_update_submitted>October 25, 2016</last_update_submitted>
  <last_update_submitted_qc>October 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Umeå University</investigator_affiliation>
    <investigator_full_name>Staffan Berglund</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Lactoferrin</keyword>
  <keyword>Infant formula</keyword>
  <keyword>Iron</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iron</mesh_term>
    <mesh_term>Lactoferrin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

